MedTrace Logo

Melatonin for Post Operative Delirium Prevention in Elderly Patients

NCT05640934 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-07-17

No results posted yet for this study

Summary

The present study will evaluate the role of melatonin prophylaxis in delirium prevention in elderly patients undergoing colorectal procedures.

Conditions

  • Delirium in Old Age

Interventions

DRUG

Melatonin

The patients will be given 5 mg melatonin the night before surgery, 12 hours before the scheduled time of surgery, followed by another 5 mg melatonin two hours before surgery.

DRUG

Placebo

The patients will be premedicated with placebo tablets, which will be administered at the same times as the melatonin group.

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • Abd-Elazeem A Elbakry, MD · Menoufia University

  • Hazem E Elsersy, MD · Menoufia University

  • Islam M El-Desoky, MD · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-10
Primary Completion
2023-07-02
Completion
2023-07-05

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05640934 on ClinicalTrials.gov